Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2890 participants.
Also called NCT05347069
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 2,890 participants
- Sponsor
- Registry
-
NCT05347069
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Japan
- Registry status
- Recruiting
Technical summary
Registry record NCT05347069. Randomized; no masking; primary purpose prevention. Start 2022-06-14 (actual); primary completion 2030-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
- Acronym
- ASA-IN
- Condition
- Stable Angina Pectoris
- Condition
- Coronary Artery Disease
- Condition
- Ischemic Heart Disease
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- No aspirin
- Lead sponsor
- Takeshi Morimoto
Record details
- Record id
cardio:ct-nct05347069- Content hash
712909c6513e318209ca6d2e4e0769dc22bcb647995912df69369af449b585ce